GUARDIAN DRUG
GenericsGUARDIAN DRUG is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology.
GUARDIAN DRUG's Key Drugs
GUARDIAN DRUG's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
GUARDIAN DRUG's Recent FDA Approvals
New NDA/BLA approvals for GUARDIAN DRUG over the last two years — novel drugs only, excluding generics and label supplements.
GUARDIAN DRUG's Therapeutic Areas
GUARDIAN DRUG's approved drugs and pipeline span 3 therapeutic areas, led by Infectious Disease and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
GUARDIAN DRUG's Top Competitors
GUARDIAN DRUG's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, WAYLIS THERAP, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
GUARDIAN DRUG Pipeline Snapshot
Active clinical trials for GUARDIAN DRUG across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1987-09-04
- Latest
- 2025-04-29
- Applications
- 6